[
    [
        {
            "time": "",
            "original_text": "2019年医药三季报业绩前瞻||三季报预期向好，关注“变化”、稳守“核心资产”【兴证医药】",
            "features": {
                "keywords": [
                    "医药",
                    "三季报",
                    "业绩",
                    "预期向好",
                    "核心资产"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2019年医药三季报业绩前瞻||三季报预期向好，关注“变化”、稳守“核心资产”【兴证医药】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]